Year-end Sale % OFF 
Abstract
To ensure the stable supply of medicines in European Union (EU) during the coronavirus disease 2019 (COVID-19) public health emergency, EU has published Guidelines on the optimal and rational supply of medicines to avoid shortages during the COVID-19 outbreak in April 2020. This guideline aimed to prompt EU Member States with concrete actions for the stable supply of medicines during the public health emergency. The guideline focused on the rational supply, allocation and use of medicines to treat COVID-19 patients but also covered any medicine at risk of shortage due to the pandemic. The main content of this guideline is introduced, which is expected to provide reference for perfecting the public health system of China.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
